Brigit Roberts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brigit Roberts has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Claire M. Rickard
The University of Queensland, Brisbane, Australia
5 shared publications - Bhajan Singh
Western Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital Nedlands Western Australia Australia
3 shared publications - Adrian Regli
Intensive Care Unit, SJOG Murdoch Hospital, Murdoch, WA, Australia; Intensive Care Unit, Fiona Stanley Hospital, Murdoch, WA, Australia; Division of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, The University of Western Australia, Nedlands, WA, Australia; Medical School, The University of Notre Dame, Fremantle, WA, Australia
2 shared publications Belinda Howe
2 shared publications- Bradley Wibrow
Sir Charles Gairdner Hospital
2 shared publications Dorrilyn Rajbhandari
2 shared publications
Latest Publications
- Open Access
- 21 March 2017
- Published by Springer Nature in BMC Anesthesiology
- Vol. 17 (1) , 1-7
Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)
Patients admitted to intensive care units (ICU) are often treated with intravenous (IV) vasopressors. Persistent hypotension and dependence on IV vasopressors in otherwise resuscitated patients lead to delay in discharge from ICU. Midodrine is an oral alpha-1 adrenergic agonist approved for treatment of symptomatic orthostatic hypotension. This trial aims to evaluate whether oral administration of midodrine is an effective adjunct to standard therapy to reduce the duration of IV vasopressor treatment, and allow earlier discharge from ICU and hospital. The MIDAS trial is an international, multicenter, randomized, double-blind, placebo-controlled clinical trial being conducted in the USA and Australia. We are targeting 120 patients. Adult patients admitted to the ICU who are resuscitated and otherwise stable on low dose IV vasopressors for at least 24 h will be considered for recruitment. Participants will be randomized to receive midodrine (20 mg) or placebo three times a day, in addition to standard care. The primary outcome is time (hours) from initiation of midodrine or placebo to discontinuation of IV vasopressors. Secondary outcomes include time (hours) from ICU admission to discharge readiness, ICU length of stay (LOS) (days), hospital LOS (days), rates of ICU readmission, and rates of adverse events related to midodrine administration. Midodrine is approved by the Food and Drug Administration (FDA) for the treatment of symptomatic orthostatic hypotension. In August 2010, FDA proposed to withdraw approval of midodrine because of lack of studies that verify the clinical benefit of the drug. We obtained Investigational New Drug (IND 113,330) approval to study its effects in critically ill patients who require IV vasopressors but are otherwise ready for discharge from the ICU. A pilot observational study in a cohort of surgical ICU patients showed that the rate of decline in vasopressor requirements increased after initiation of midodrine treatment. We hypothesize that midodrine administration is effective to wean IV vasopressors and shorten ICU and hospital LOS. This trial may have significant implications on lowering costs of hospital care and obtaining FDA approval for new indications for midodrine. This study has been registered at clinicaltrials.gov on 02/09/2012 (NCT01531959).
- 21 March 2017
- Published by Springer Nature in BMC Anesthesiology
- Vol. 17 (1) , 1-7
Open AccessMidodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)
Patients admitted to intensive care units (ICU) are often treated with intravenous (IV) vasopressors. Persistent hypotension and dependence on IV vasopressors in otherwise resuscitated patients lead to delay in discharge from ICU. Midodrine is an oral alpha-1 adrenergic agonist approved for treatment of symptomatic orthostatic hypotension. This trial aims to evaluate whether oral administration of midodrine is an effective adjunct to standard therapy to reduce the duration of IV vasopressor treatment, and allow earlier discharge from ICU and hospital. The MIDAS trial is an international, multicenter, randomized, double-blind, placebo-controlled clinical trial being conducted in the USA and Australia. We are targeting 120 patients. Adult patients admitted to the ICU who are resuscitated and otherwise stable on low dose IV vasopressors for at least 24 h will be considered for recruitment. Participants will be randomized to receive midodrine (20 mg) or placebo three times a day, in addition to standard care. The primary outcome is time (hours) from initiation of midodrine or placebo to discontinuation of IV vasopressors. Secondary outcomes include time (hours) from ICU admission to discharge readiness, ICU length of stay (LOS) (days), hospital LOS (days), rates of ICU readmission, and rates of adverse events related to midodrine administration. Midodrine is approved by the Food and Drug Administration (FDA) for the treatment of symptomatic orthostatic hypotension. In August 2010, FDA proposed to withdraw approval of midodrine because of lack of studies that verify the clinical benefit of the drug. We obtained Investigational New Drug (IND 113,330) approval to study its effects in critically ill patients who require IV vasopressors but are otherwise ready for discharge from the ICU. A pilot observational study in a cohort of surgical ICU patients showed that the rate of decline in vasopressor requirements increased after initiation of midodrine treatment. We hypothesize that midodrine administration is effective to wean IV vasopressors and shorten ICU and hospital LOS. This trial may have significant implications on lowering costs of hospital care and obtaining FDA approval for new indications for midodrine. This study has been registered at clinicaltrials.gov on 02/09/2012 (NCT01531959).
- Open Access
- 6 January 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-10
Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial
Background: Delirium is an acute state of brain dysfunction characterised by fluctuating inattention and cognitive disturbances, usually due to illness. It occurs commonly in the intensive care unit (ICU), and it is associated with greater morbidity and mortality. It is likely that disturbances of sleep and of the day-night cycle play a significant role. Melatonin is a naturally occurring, safe and cheap hormone that can be administered to improve sleep. The main aim of this trial will be to determine whether prophylactic melatonin administered to critically ill adults, when compared with placebo, decreases the rate of delirium. Methods: This trial will be a multi-centre, randomised, placebo-controlled study conducted in closed ICUs in Australia. Our aim is to enrol 850 adult patients with an expected ICU length of stay (LOS) of 72 h or more. Eligible patients for whom there is consent will be randomised to receive melatonin 4 mg enterally or placebo in a 1:1 ratio according to a computer-generated randomisation list, stratified by site. The study drug will be indistinguishable from placebo. Patients, doctors, nurses, investigators and statisticians will be blinded. Melatonin or placebo will be administered once per day at 21:00 until ICU discharge or 14 days after enrolment, whichever occurs first. Trained staff will assess patients twice daily to determine the presence or absence of delirium using the Confusion Assessment Method for the ICU score. Data will also be collected on demographics, the overall prevalence of delirium, duration and severity of delirium, sleep quality, participation in physiotherapy sessions, ICU and hospital LOS, morbidity and mortality, and healthcare costs. A subgroup of 100 patients will undergo polysomnographic testing to further evaluate the quality of sleep. Discussion: Delirium is a significant issue in ICU because of its frequency and associated poorer outcomes. This trial will be the largest evaluation of melatonin as a prophylactic agent to prevent delirium in the critically ill population. This study will also provide one of the largest series of polysomnographic testing done in ICU. Trial registration: Australian New Zealand Clinical Trial Registry (ANZCTR) number: ACTRN12616000436471. Registered on 20 December 2015.
- 6 January 2017
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-10
Open AccessProphylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial
Background: Delirium is an acute state of brain dysfunction characterised by fluctuating inattention and cognitive disturbances, usually due to illness. It occurs commonly in the intensive care unit (ICU), and it is associated with greater morbidity and mortality. It is likely that disturbances of sleep and of the day-night cycle play a significant role. Melatonin is a naturally occurring, safe and cheap hormone that can be administered to improve sleep. The main aim of this trial will be to determine whether prophylactic melatonin administered to critically ill adults, when compared with placebo, decreases the rate of delirium. Methods: This trial will be a multi-centre, randomised, placebo-controlled study conducted in closed ICUs in Australia. Our aim is to enrol 850 adult patients with an expected ICU length of stay (LOS) of 72 h or more. Eligible patients for whom there is consent will be randomised to receive melatonin 4 mg enterally or placebo in a 1:1 ratio according to a computer-generated randomisation list, stratified by site. The study drug will be indistinguishable from placebo. Patients, doctors, nurses, investigators and statisticians will be blinded. Melatonin or placebo will be administered once per day at 21:00 until ICU discharge or 14 days after enrolment, whichever occurs first. Trained staff will assess patients twice daily to determine the presence or absence of delirium using the Confusion Assessment Method for the ICU score. Data will also be collected on demographics, the overall prevalence of delirium, duration and severity of delirium, sleep quality, participation in physiotherapy sessions, ICU and hospital LOS, morbidity and mortality, and healthcare costs. A subgroup of 100 patients will undergo polysomnographic testing to further evaluate the quality of sleep. Discussion: Delirium is a significant issue in ICU because of its frequency and associated poorer outcomes. This trial will be the largest evaluation of melatonin as a prophylactic agent to prevent delirium in the critically ill population. This study will also provide one of the largest series of polysomnographic testing done in ICU. Trial registration: Australian New Zealand Clinical Trial Registry (ANZCTR) number: ACTRN12616000436471. Registered on 20 December 2015.
- Open Access
- 1 September 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (3) , 213-217
Routine coagulation testing in intensive care
- 1 September 2016
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 18 (3) , 213-217
Open AccessRoutine coagulation testing in intensive care
- Open Access
- 26 October 2012
- Published by Springer Nature in Critical Care
- Vol. 16 (5) , R208
Matching positive end-expiratory pressure to intra-abdominal pressure improves oxygenation in a porcine sick lung model of intra-abdominal hypertension
Introduction: Intra-abdominal hypertension (IAH) causes atelectasis, reduces lung volumes and increases respiratory system elastance. Positive end-expiratory pressure (PEEP) in the setting of IAH and healthy lungs improves lung volumes but not oxygenation. However, critically ill patients with IAH often suffer from acute lung injury (ALI). This study, therefore, examined the respiratory and cardiac effects of positive end-expiratory pressure in an animal model of IAH, with sick lungs. Methods: Nine pigs were anesthetized and ventilated (48 +/- 6 kg). Lung injury was induced with oleic acid. Three levels of intra-abdominal pressure (baseline, 18, and 22 mmHg) were randomly generated. At each level of intra-abdominal pressure, three levels of PEEP were randomly applied: baseline (5 cmH2O), moderate (0.5 × intra-abdominal pressure), and high (1.0 × intra-abdominal pressure). We measured end-expiratory lung volumes, arterial oxygen levels, respiratory mechanics, and cardiac output 10 minutes after each new IAP and PEEP setting. Results: At baseline PEEP, IAH (22 mmHg) decreased oxygen levels (-55%, P P = 0.007). At IAP of 22 mmHg, moderate and high PEEP increased oxygen levels (+60%, P = 0.04 and +162%, P P = 0.02 and +279%, P P = 0.04). Shunt and dead-space fraction inversely correlated with oxygen levels and end-expiratory lung volumes. In the presence of IAH, lung, chest wall and respiratory system elastance increased. Subsequently, PEEP decreased respiratory system elastance by decreasing chest wall elastance. Conclusions: In a porcine sick lung model of IAH, PEEP matched to intra-abdominal pressure led to increased lung volumes and oxygenation and decreased chest wall elastance shunt and dead-space fraction. High PEEP decreased cardiac output. The study shows that lung injury influences the effects of IAH and PEEP on oxygenation and respiratory mechanics. Our findings support the application of PEEP in the setting of acute lung injury and IAH.
- 26 October 2012
- Published by Springer Nature in Critical Care
- Vol. 16 (5) , R208
Open AccessMatching positive end-expiratory pressure to intra-abdominal pressure improves oxygenation in a porcine sick lung model of intra-abdominal hypertension
Introduction: Intra-abdominal hypertension (IAH) causes atelectasis, reduces lung volumes and increases respiratory system elastance. Positive end-expiratory pressure (PEEP) in the setting of IAH and healthy lungs improves lung volumes but not oxygenation. However, critically ill patients with IAH often suffer from acute lung injury (ALI). This study, therefore, examined the respiratory and cardiac effects of positive end-expiratory pressure in an animal model of IAH, with sick lungs. Methods: Nine pigs were anesthetized and ventilated (48 +/- 6 kg). Lung injury was induced with oleic acid. Three levels of intra-abdominal pressure (baseline, 18, and 22 mmHg) were randomly generated. At each level of intra-abdominal pressure, three levels of PEEP were randomly applied: baseline (5 cmH2O), moderate (0.5 × intra-abdominal pressure), and high (1.0 × intra-abdominal pressure). We measured end-expiratory lung volumes, arterial oxygen levels, respiratory mechanics, and cardiac output 10 minutes after each new IAP and PEEP setting. Results: At baseline PEEP, IAH (22 mmHg) decreased oxygen levels (-55%, P P = 0.007). At IAP of 22 mmHg, moderate and high PEEP increased oxygen levels (+60%, P = 0.04 and +162%, P P = 0.02 and +279%, P P = 0.04). Shunt and dead-space fraction inversely correlated with oxygen levels and end-expiratory lung volumes. In the presence of IAH, lung, chest wall and respiratory system elastance increased. Subsequently, PEEP decreased respiratory system elastance by decreasing chest wall elastance. Conclusions: In a porcine sick lung model of IAH, PEEP matched to intra-abdominal pressure led to increased lung volumes and oxygenation and decreased chest wall elastance shunt and dead-space fraction. High PEEP decreased cardiac output. The study shows that lung injury influences the effects of IAH and PEEP on oxygenation and respiratory mechanics. Our findings support the application of PEEP in the setting of acute lung injury and IAH.
- 30 November 2011
- Published by Elsevier in Australian Critical Care
- Vol. 24 (4) , 259-268
Intensive Care Research Coordinators in Australia and New Zealand: A cross-sectional survey of demographics, responsibilities, job satisfaction and importance
- 30 November 2011
- Published by Elsevier in Australian Critical Care
- Vol. 24 (4) , 259-268
Intensive Care Research Coordinators in Australia and New Zealand: A cross-sectional survey of demographics, responsibilities, job satisfaction and importance
- 1 June 2011
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 27 (3) , 129-137
The intensive care research coordinator position in Australia and New Zealand: Self-perception of professional development priorities and “best” and “worst” aspects of the position. A cross-sectional web-based study
- 1 June 2011
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 27 (3) , 129-137
The intensive care research coordinator position in Australia and New Zealand: Self-perception of professional development priorities and “best” and “worst” aspects of the position. A cross-sectional web-based study
- Open Access
- 2 July 2010
- Published by Springer Nature in Critical Care
- Vol. 14 (4) , R128
Commonly applied positive end-expiratory pressures do not prevent functional residual capacity decline in the setting of intra-abdominal hypertension: a pig model
Introduction: Intra-abdominal hypertension is common in critically ill patients and is associated with increased morbidity and mortality. The optimal ventilation strategy remains unclear in these patients. We examined the effect of positive end-expiratory pressures (PEEP) on functional residual capacity (FRC) and oxygen delivery in a pig model of intra-abdominal hypertension. Methods: Thirteen adult pigs received standardised anaesthesia and ventilation. We randomised three levels of intra-abdominal pressure (3 mmHg (baseline), 18 mmHg, and 26 mmHg) and four commonly applied levels of PEEP (5, 8, 12 and 15 cmH2O). Intra-abdominal pressures were generated by inflating an intra-abdominal balloon. We measured intra-abdominal (bladder) pressure, functional residual capacity, cardiac output, haemoglobin and oxygen saturation, and calculated oxygen delivery. Results: Raised intra-abdominal pressure decreased FRC but did not change cardiac output. PEEP increased FRC at baseline intra-abdominal pressure. The decline in FRC with raised intra-abdominal pressure was partly reversed by PEEP at 18 mmHg intra-abdominal pressure and not at all at 26 mmHg intra-abdominal pressure. PEEP significantly decreased cardiac output and oxygen delivery at baseline and at 26 mmHg intra-abdominal pressure but not at 18 mmHg intra-abdominal pressure. Conclusions: In a pig model of intra-abdominal hypertension, PEEP up to 15 cmH2O did not prevent the FRC decline caused by intra-abdominal hypertension and was associated with reduced oxygen delivery as a consequence of reduced cardiac output. This implies that PEEP levels inferior to the corresponding intra-abdominal pressures cannot be recommended to prevent FRC decline in the setting of intra-abdominal hypertension.
- 2 July 2010
- Published by Springer Nature in Critical Care
- Vol. 14 (4) , R128
Open AccessCommonly applied positive end-expiratory pressures do not prevent functional residual capacity decline in the setting of intra-abdominal hypertension: a pig model
Introduction: Intra-abdominal hypertension is common in critically ill patients and is associated with increased morbidity and mortality. The optimal ventilation strategy remains unclear in these patients. We examined the effect of positive end-expiratory pressures (PEEP) on functional residual capacity (FRC) and oxygen delivery in a pig model of intra-abdominal hypertension. Methods: Thirteen adult pigs received standardised anaesthesia and ventilation. We randomised three levels of intra-abdominal pressure (3 mmHg (baseline), 18 mmHg, and 26 mmHg) and four commonly applied levels of PEEP (5, 8, 12 and 15 cmH2O). Intra-abdominal pressures were generated by inflating an intra-abdominal balloon. We measured intra-abdominal (bladder) pressure, functional residual capacity, cardiac output, haemoglobin and oxygen saturation, and calculated oxygen delivery. Results: Raised intra-abdominal pressure decreased FRC but did not change cardiac output. PEEP increased FRC at baseline intra-abdominal pressure. The decline in FRC with raised intra-abdominal pressure was partly reversed by PEEP at 18 mmHg intra-abdominal pressure and not at all at 26 mmHg intra-abdominal pressure. PEEP significantly decreased cardiac output and oxygen delivery at baseline and at 26 mmHg intra-abdominal pressure but not at 18 mmHg intra-abdominal pressure. Conclusions: In a pig model of intra-abdominal hypertension, PEEP up to 15 cmH2O did not prevent the FRC decline caused by intra-abdominal hypertension and was associated with reduced oxygen delivery as a consequence of reduced cardiac output. This implies that PEEP levels inferior to the corresponding intra-abdominal pressures cannot be recommended to prevent FRC decline in the setting of intra-abdominal hypertension.
- 23 August 2007
- Published by Wiley in Journal of Clinical Nursing
- Vol. 16 (9) , 1669-1677
Factual memories of ICU: recall at two years post‐discharge and comparison with delirium status during ICU admission – a multicentre cohort study
Aims and objective. To examine the relationship between observed delirium in ICU and patients’ recall of factual events up to two years after discharge.Background. People, the environment, and procedures are frequently cited memories of actual events encountered in ICU. These are often perceived as stressors to the patients and the presence of several such stressors has been associated with the development of reduced health‐related quality of life or post‐traumatic stress syndrome.Design. Prospective cohort study using interview technique.Method. The cohort was assembled from 152 patients who participated in a previously conducted multi‐centre study of delirium incidence in Australian ICUs. The interviews involved a mixture of closed‐ and open‐ended questions. Qualitative responses regarding factual memories were analysed using thematic analysis. A five‐point Likert scale with answers from ‘always’ to ‘never’ was used to ask about current experiences of dream, anxiety, sleep problems, fears, irritability and/or mood swings. Scoring ranged from 6 to 30 with a mid‐point value of 18 indicating a threshold value for the diagnosis of post‐traumatic stress syndrome. A P‐value of Results. Forty‐one (40%) out of 103 potential participants consented to take part in the follow‐up interview; 18 patients (44%) had been delirious and 23 patients (56%) non‐delirious during the ICU admission. The non‐participants (n = 62) formed a control group to ensure a representative sample; 83% (n = 34) reported factual memories either with or without recall of dreaming. Factual memories were significantly less common (66% cf. 96%) in delirious patients (OR 0·09, 95%CI 0·01–0·85, p = 0·035). Five topics emerged from the thematic analysis: ‘procedures’, ‘staff’, ‘comfort’, ‘visitors’, and ‘events’. Based on the current experiences, five patients (12%, four non‐delirious and one delirious) scored ≥18 indicative of symptoms of post‐traumatic stress syndrome; this did not reach statistical significance. Memory of transfer out of ICU was less frequent among the delirious patients (56%, n = 10) than among the non‐delirious patients (87%, n = 20) (p = 0·036).Conclusion. Most patients have factual memories of their ICU stay. However, delirious patients had significantly less factual recall than non‐delirious patients. Adverse psychological sequelae expressed as post‐traumatic stress syndrome was uncommon in our study. Every attempt must be made to ensure that the ICU environment is as hospitable as possible to decrease the stress of critical illness. Post‐ICU follow‐up should include filling in the ‘missing gaps’, particularly for delirious patients. Ongoing explanations and a caring environment may assist the patient in making a complete recovery both physically and mentally.Relevance to clinical practice. This study highlights the need for continued patient information, re‐assurance and optimized comfort. While health care professionals cannot remove the stressors of the ICU treatments, we must minimize the impact of the stay. It must be remembered that most patients are aware of their surroundings while they are in the ICU and it should, therefore, be part of ICU education to include issues regarding all aspects of patient care in this particularly vulnerable subset of patients to optimize their feelings of security, comfort and self‐respect.
- 23 August 2007
- Published by Wiley in Journal of Clinical Nursing
- Vol. 16 (9) , 1669-1677
Factual memories of ICU: recall at two years post‐discharge and comparison with delirium status during ICU admission – a multicentre cohort study
Aims and objective. To examine the relationship between observed delirium in ICU and patients’ recall of factual events up to two years after discharge.Background. People, the environment, and procedures are frequently cited memories of actual events encountered in ICU. These are often perceived as stressors to the patients and the presence of several such stressors has been associated with the development of reduced health‐related quality of life or post‐traumatic stress syndrome.Design. Prospective cohort study using interview technique.Method. The cohort was assembled from 152 patients who participated in a previously conducted multi‐centre study of delirium incidence in Australian ICUs. The interviews involved a mixture of closed‐ and open‐ended questions. Qualitative responses regarding factual memories were analysed using thematic analysis. A five‐point Likert scale with answers from ‘always’ to ‘never’ was used to ask about current experiences of dream, anxiety, sleep problems, fears, irritability and/or mood swings. Scoring ranged from 6 to 30 with a mid‐point value of 18 indicating a threshold value for the diagnosis of post‐traumatic stress syndrome. A P‐value of Results. Forty‐one (40%) out of 103 potential participants consented to take part in the follow‐up interview; 18 patients (44%) had been delirious and 23 patients (56%) non‐delirious during the ICU admission. The non‐participants (n = 62) formed a control group to ensure a representative sample; 83% (n = 34) reported factual memories either with or without recall of dreaming. Factual memories were significantly less common (66% cf. 96%) in delirious patients (OR 0·09, 95%CI 0·01–0·85, p = 0·035). Five topics emerged from the thematic analysis: ‘procedures’, ‘staff’, ‘comfort’, ‘visitors’, and ‘events’. Based on the current experiences, five patients (12%, four non‐delirious and one delirious) scored ≥18 indicative of symptoms of post‐traumatic stress syndrome; this did not reach statistical significance. Memory of transfer out of ICU was less frequent among the delirious patients (56%, n = 10) than among the non‐delirious patients (87%, n = 20) (p = 0·036).Conclusion. Most patients have factual memories of their ICU stay. However, delirious patients had significantly less factual recall than non‐delirious patients. Adverse psychological sequelae expressed as post‐traumatic stress syndrome was uncommon in our study. Every attempt must be made to ensure that the ICU environment is as hospitable as possible to decrease the stress of critical illness. Post‐ICU follow‐up should include filling in the ‘missing gaps’, particularly for delirious patients. Ongoing explanations and a caring environment may assist the patient in making a complete recovery both physically and mentally.Relevance to clinical practice. This study highlights the need for continued patient information, re‐assurance and optimized comfort. While health care professionals cannot remove the stressors of the ICU treatments, we must minimize the impact of the stay. It must be remembered that most patients are aware of their surroundings while they are in the ICU and it should, therefore, be part of ICU education to include issues regarding all aspects of patient care in this particularly vulnerable subset of patients to optimize their feelings of security, comfort and self‐respect.
- 1 October 2006
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 22 (5) , 264-273
Patients’ dreams in ICU: Recall at two years post discharge and comparison to delirium status during ICU admission
- 1 October 2006
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 22 (5) , 264-273
Patients’ dreams in ICU: Recall at two years post discharge and comparison to delirium status during ICU admission
- 20 April 2006
- Published by Wiley in Nursing in Critical Care
- Vol. 11 (3) , 128-135
The best and worst aspects of the ICU research coordinator role
Background : The Research Coordinator (RC) role is a relative new addition to staffing profiles in Australasian Intensive Care Units (ICUs). The RC plays a pivotal role in conducting ethically and scientifically sound research. There have been anecdotal reports of the RC role in various speciality areas. However, limited research has been undertaken into the role, and only one study has been published from the intensive care setting.Aim : To evaluate which factors the RC found to be the best and worst attributes of the role.Methods : A cross‐sectional web‐based cohort study was conducted in 2004 collecting free text information from RCs in ICUs in Australia and New Zealand.Results : Forty‐nine participants (71%) completed the study with 273 entries into the two categories of ‘best’ (60%) and ‘worst’ (40%) aspects of the role. We identified four thematic clusters in both categories: (1) ‘How the job was structured’ (2) ‘The worth of the job’ (3) ‘What the work involves’ and (4) ‘Who I work with’. Both categories received proportionally the same number of responses in each theme with (1) the most frequent and (4) the least number of entries.Conclusion : There is much variation between RCs in almost every descriptor of the role. The Australasian Intensive Care RC values autonomy, respect and intellectual stimulation with the scope for extending the role to suit the individual and finds isolation, under‐recognition and workload, often not sufficiently compensated, to be the worst aspects of the position.
- 20 April 2006
- Published by Wiley in Nursing in Critical Care
- Vol. 11 (3) , 128-135
The best and worst aspects of the ICU research coordinator role
Background : The Research Coordinator (RC) role is a relative new addition to staffing profiles in Australasian Intensive Care Units (ICUs). The RC plays a pivotal role in conducting ethically and scientifically sound research. There have been anecdotal reports of the RC role in various speciality areas. However, limited research has been undertaken into the role, and only one study has been published from the intensive care setting.Aim : To evaluate which factors the RC found to be the best and worst attributes of the role.Methods : A cross‐sectional web‐based cohort study was conducted in 2004 collecting free text information from RCs in ICUs in Australia and New Zealand.Results : Forty‐nine participants (71%) completed the study with 273 entries into the two categories of ‘best’ (60%) and ‘worst’ (40%) aspects of the role. We identified four thematic clusters in both categories: (1) ‘How the job was structured’ (2) ‘The worth of the job’ (3) ‘What the work involves’ and (4) ‘Who I work with’. Both categories received proportionally the same number of responses in each theme with (1) the most frequent and (4) the least number of entries.Conclusion : There is much variation between RCs in almost every descriptor of the role. The Australasian Intensive Care RC values autonomy, respect and intellectual stimulation with the scope for extending the role to suit the individual and finds isolation, under‐recognition and workload, often not sufficiently compensated, to be the worst aspects of the position.